{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T20:39:52Z","timestamp":1790023192232,"version":"4.0.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2001,11,21]],"date-time":"2001-11-21T00:00:00Z","timestamp":1006300800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"DOI":"10.1186\/1471-2466-1-2","type":"journal-article","created":{"date-parts":[[2002,10,11]],"date-time":"2002-10-11T18:42:27Z","timestamp":1034361747000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Serial counts of Mycobacterium tuberculosis in sputum as surrogate markers of the sterilising activity of rifampicin and pyrazinamide in treating pulmonary tuberculosis"],"prefix":"10.1186","volume":"1","author":[{"given":"Richard","family":"Brindle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Odhiambo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Mitchison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2001,11,21]]},"reference":[{"key":"2_CR1","unstructured":"Tuberculosis Scientific Blueprint for TB Drug Development. Tuberculosis. 2001, 81 (Suppl.1): 1-52. 10.1054\/tube.2001.0288."},{"key":"2_CR2","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1164\/ajrccm\/147.4.1062","volume":"147","author":"DA Mitchison","year":"1993","unstructured":"Mitchison DA: Assessment of new sterilizing drugs for treating pulmonary tuberculosis by culture at 2 months. Am Rev Respir Dis. 1993, 147: 1062-1063.","journal-title":"Am Rev Respir Dis"},{"key":"2_CR3","doi-asserted-by":"crossref","first-page":"72S","DOI":"10.1111\/j.1365-2672.1996.tb04835.x","volume":"81","author":"DA Mitchison","year":"1996","unstructured":"Mitchison DA: Modern methods for assessing the drugs used in the chemotherapy of mycobacterial disease. J Appl Bacteriol. 1996, 81: 72S-80S.","journal-title":"J Appl Bacteriol"},{"key":"2_CR4","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1164\/ajrccm.161.4.9903087","volume":"161","author":"RS Wallis","year":"2000","unstructured":"Wallis RS, Perkins MD, Phillips M, Joloba M, Namale A, Johnson JL, Whalen CC, Teixeira L, Demchuk B, Dietze R, et al: Predicting the outcome of therapy for pulmonary tuberculosis. Am J Respir Crit Care Med. 2000, 161: 1076-1080.","journal-title":"Am J Respir Crit Care Med"},{"key":"2_CR5","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1378\/chest.113.2.379","volume":"113","author":"MD Epstein","year":"1997","unstructured":"Epstein MD, Schluger NW, Davidow AL, Bond SB, Rom WN, Hanna B: Time to detection of M. tuberculosis in sputum culture correlates with outcome in patients receiving treatment for pulmonary tuberculosis. Chest. 1997, 113: 379-386.","journal-title":"Chest"},{"key":"2_CR6","first-page":"939","volume":"121","author":"A Jindani","year":"1980","unstructured":"Jindani A, Aber VR, Edwards EA, Mitchison DA: The early bactericidal activity of drugs in patients with pulmonary tuberculosis. Am Rev Respir Dis. 1980, 121: 939-949.","journal-title":"Am Rev Respir Dis"},{"key":"2_CR7","first-page":"185","volume-title":"In: Bailliere's Clinical Infectious Diseases: Mycobacterial Diseases Part II. (Edited by Malin A, McAdam KPWJ) London, Bailliere Tindall","author":"DA Mitchison","year":"1997","unstructured":"Mitchison DA, Sturm WA: The measurement of early bactericidal activity. In: Bailliere's Clinical Infectious Diseases: Mycobacterial Diseases Part II. (Edited by Malin A, McAdam KPWJ) London, Bailliere Tindall. 1997, 185-206."},{"key":"2_CR8","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1093\/jac\/45.6.859","volume":"45","author":"FA Sirgel","year":"2000","unstructured":"Sirgel FA, Donald PR, Odhiambo J, Githui W, Umapathy KC, Paramasivan CN, Tam CM, Lam KM, Lam CW, Sole KM, Mitchison DA, and the EBA Collaborative Study Group: A multicentre study of the early bactericidal activity of anti-tuberculosis drugs. J Antimicrob Chemother. 2000, 45: 859-870. 10.1093\/jac\/45.6.859.","journal-title":"J Antimicrob Chemother"},{"key":"2_CR9","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1164\/ajrccm\/147.4.958","volume":"147","author":"RJ Brindle","year":"1993","unstructured":"Brindle RJ, Nunn PP, Githui W, Allen BW, Gathua S, Waiyaki P: Quantitative bacillary response to treatment in HIV-associated pulmonary tuberculosis. Am Rev Respir Dis. 1993, 147: 958-961.","journal-title":"Am Rev Respir Dis"},{"key":"2_CR10","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/S0140-6736(74)91411-1","volume":"2","author":"East African\/British Medical Research Council","year":"1974","unstructured":"East African\/British Medical Research Council: Controlled clinical trial of four short-course (6-month) regimens of chemotherapy for treatment of pulmonary tuberculosis. Third report. Lancet. 1974, 2: 237-240. 10.1016\/S0140-6736(74)91411-1.","journal-title":"Lancet"},{"key":"2_CR11","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1093\/jac\/47.2.177","volume":"47","author":"F Sirgel","year":"2001","unstructured":"Sirgel F, Venter A, Mitchison D: Sources of variation in studies of the early bactericidal activity of antituberculosis drugs. J Antimicrob Chemother. 2001, 47: 177-182. 10.1093\/jac\/47.2.177.","journal-title":"J Antimicrob Chemother"},{"key":"2_CR12","first-page":"367","volume":"123","author":"JM Dickinson","year":"1981","unstructured":"Dickinson JM, Mitchison DA: Experimental models to explain the high sterilizing activity of rifampicin in the chemotherapy of tuberculosis. Am Rev Respir Dis. 1981, 123: 367-371.","journal-title":"Am Rev Respir Dis"},{"key":"2_CR13","doi-asserted-by":"publisher","first-page":"6358","DOI":"10.1128\/JB.182.22.6358-6365.2000","volume":"182","author":"Y Hu","year":"2000","unstructured":"Hu Y, Mangan JA, Dhillon J, Sole KM, Mitchison DA, Butcher PD, Coates ARM: Detection of mRNA transcripts and active transcription in persistent Mycobacterium tuberculosis induced by exposure to rifampicin or pyrazinamide. J Bacteriol. 2000, 182: 6358-6365. 10.1128\/JB.182.22.6358-6365.2000.","journal-title":"J Bacteriol"},{"key":"2_CR14","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1084\/jem.104.5.763","volume":"104","author":"RM McCune","year":"1956","unstructured":"McCune RM, Tompsett R, McDermott W: The fate of Mycobacterium tuberculosis in mouse tissues as determined by the microbial enumeration technique. J Exp Med. 1956, 104: 763-803.","journal-title":"J Exp Med"},{"key":"2_CR15","first-page":"155","volume":"86","author":"FJH Botha","year":"1996","unstructured":"Botha FJH, Sirgel FA, Parkin DP, van de Wal BW, Donald PR, Mitchison DA: Early bactericidal activity of ethambutol, pyrazinamide and the fixed combination of isoniazid, rifampicin and pyrazinamide (Rifater) in patients with pulmonary tuberculosis. S Afr Med J. 1996, 86: 155-158.","journal-title":"S Afr Med J"},{"key":"2_CR16","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/0041-3879(85)90040-6","volume":"66","author":"DA Mitchison","year":"1985","unstructured":"Mitchison DA: The action of antituberculosis drugs in short-course chemotherapy. Tubercle. 1985, 66: 219-225.","journal-title":"Tubercle"},{"key":"2_CR17","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/0041-3879(86)90027-9","volume":"67","author":"East and Central African\/British Medical Research Council (fifth Collaborative Study)","year":"1986","unstructured":"East and Central African\/British Medical Research Council (fifth Collaborative Study): Controlled clinical trial of 4 short-course regimens of chemotherapy (three 6-month and one 8-month) for pulmonary tuberculosis. Final report. Tubercle. 1986, 67: 5-15.","journal-title":"Tubercle"},{"key":"2_CR18","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1164\/ajrccm\/143.4_Pt_1.700","volume":"143","author":"Hong Kong Chest Service\/British Medical Research Council","year":"1991","unstructured":"Hong Kong Chest Service\/British Medical Research Council: Controlled trial of 2, 4 and 6 months of pyrazinamide in 6-month, 3 \u00d7 weekly regimens for smear-positive pulmonary tuberculosis, including an assessment of a combined preparation of isoniazid, rifampicin and pyrazinamide. Am Rev Respir Dis. 1991, 143: 700-706.","journal-title":"Am Rev Respir Dis"},{"key":"2_CR19","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1093\/jac\/29.5.477","volume":"29","author":"DA Mitchison","year":"1992","unstructured":"Mitchison DA: The Garrod Lecture. Understanding the chemotherapy of tuberculosis-current problems. J Antimicrob Chemother. 1992, 29: 477-493.","journal-title":"J Antimicrob Chemother"},{"key":"2_CR20","volume-title":"New York, Springer","author":"G Canetti","year":"1955","unstructured":"Canetti G: The tubercle bacillus in the pulmonary lesion of man: histobacteriology and its bearing on the therapy of pulmonary tuberculosis. New York, Springer. 1955"},{"key":"2_CR21","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1164\/ajrccm\/146.4.849","volume":"146","author":"P Nunn","year":"1992","unstructured":"Nunn P, Brindle R, Carpenter L, Odhiambo J, Wasunna K, Newnham R, Githui W, Gathua S, Omwega M, McAdam K: Cohort study of human immunodeficiency virus infection in patients with tuberculosis in Nairobi, Kenya. Analysis of early (6 month) mortality. Am Rev Respir Dis. 1992, 146: 849-854.","journal-title":"Am Rev Respir Dis"},{"key":"2_CR22","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1099\/00222615-5-2-165","volume":"5","author":"DA Mitchison","year":"1972","unstructured":"Mitchison DA, Allen BW, Carrol L, Dickinson JM, Aber VR: A selective oleic acid albumin agar medium for tubercle bacilli. J Med Microbiol. 1972, 5: 165-175.","journal-title":"J Med Microbiol"},{"key":"2_CR23","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2307\/2348109","volume":"42","author":"P Royston","year":"1993","unstructured":"Royston P: A toolkit for testing for non-normality in complete and censored samples. Statistician. 1993, 42: 37-43.","journal-title":"Statistician"},{"key":"2_CR24","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.2517-6161.1964.tb00553.x","volume":"26","author":"GEP Box","year":"1964","unstructured":"Box GEP, Cox DR: An analysis of transformations. J R Stat Soc. 1964, 26: 211-243.","journal-title":"J R Stat Soc"},{"key":"2_CR25","volume-title":"Reading, MA. Addison-Wesley Publishing Company","author":"JW Tukey","year":"1977","unstructured":"Tukey JW: Exploratory Data Analysis. Reading, MA. Addison-Wesley Publishing Company. 1977"},{"key":"2_CR26","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1084\/jem.104.5.763","volume":"104","author":"RM McCune","year":"1956","unstructured":"McCune RM, Tompsett R, McDermott W: The fate of Mycobacterium tuberculosis in mouse tissues as determined by the microbial enumeration technique. II. The conversion of tuberculous infection to the latent state by the administration of pyrazinamide and a companion drug. J Exp Med. 1956, 104: 763-803.","journal-title":"J Exp Med"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2466-1-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2466-1-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2466-1-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2466-1-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T15:42:31Z","timestamp":1726242151000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/1471-2466-1-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,11,21]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2001,12]]}},"alternative-id":["2"],"URL":"https:\/\/doi.org\/10.1186\/1471-2466-1-2","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,11,21]]},"assertion":[{"value":"9 October 2001","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2001","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2001","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"2"}}